Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes-Reference-Cited by-同舟云学术

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes

Published:2021-03-23 Issue:2 Volume:4 Page:543-552
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Agin-Liebes Gabrielle¹²^ORCID,Haas Trevor F.³⁴,Lancelotta Rafael⁵,Uthaug Malin V.⁶,Ramaekers Johannes G.⁶,Davis Alan K.⁷⁸

Affiliation:

1. Department of Psychiatry, University of California, San Francisco, 1001 Potrero Ave., San Francisco, California 94110, United States

2. Zuckerberg San Francisco General Hospital, 1001 Potrero Ave., Bldg. 80, San Francisco, California 94110, United States

3. University of California, Davis, School of Medicine, 4610 X Street, Sacramento, California 95817, United States

4. Department of Psychiatry and Behavioral Sciences, University of Southern California, 3620 McClintock Ave., Los Angeles, California 90089-0001, United States

5. Habituating to Wholeness, LLC, 6500 W 13th Ave, Lakewood, Colorado 80214, United States

6. Department of Clinical Psychological Science, Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 40, 6229, Maastricht, Limburg 6200 MD, The Netherlands

7. College of Social Work, The Ohio State University, 1947 College Road, Columbus, Ohio 43210, United States

8. Center for Psychedelic and Consciousness Research, Johns Hopkins University, 5510 Nathan Shock Drive, Baltimore, Maryland 21224, United States

Funder

Steven and Alexandra Cohen Foundation

National Institute on Drug Abuse

Blake Mycoskie

Matt Mullenweg

Craig Nerenberg

Tim Ferriss

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.1c00018

Reference65 articles.

1. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013

2. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

3. Epidemiology and treatment of depression in patients with chronic medical illness

4. World Health Organization (WHO). (2001) An overview of a strategy to improve the mental health of underserved populations, WHO, Geneva, Switzerland.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of research on psychedelics for depression treatment;Heliyon;2024-09

2. The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder;Current Addiction Reports;2024-06-25

3. Choosing Suggested Integration Goals;EMBARK Psychedelic Therapy for Depression;2024-04-23

4. Working Within the EMBARK Domains Cheat Sheet;EMBARK Psychedelic Therapy for Depression;2024-04-23

5. Medicine Sessions;EMBARK Psychedelic Therapy for Depression;2024-04-23